Transcode Therapeutics, Inc. (RNAZ) — EPS (Diluted)

Annual figures by fiscal year, from SEC filings.

2020: $-0.512021: $-0.812022: $-1082.792023: $-3419.012024: $-1336.632025: $-52.59$-52.59
2020EPS (Diluted) (USD/shares)2025
Fiscal YearEPS (Diluted)Change YoY
2025$-52.59+96.1%
2024$-1336.63+60.9%
2023$-3419.01-215.8%
2022$-1082.79-133577.8%
2021$-0.81-58.8%
2020$-0.51